Jump to content
RemedySpot.com

HIV and AZT

Rate this topic


Guest guest

Recommended Posts

Guest guest

HIV and AZT

By Regush

I confess. I tried but couldn’t shut down my computer when I took some time off

from writing this column. The extra leisure allowance that flooded into my life

allowed me to do a little snooping into Internet health sites, like drkoop.com,

for example.

I had been planning to write about a growing debate over whether newborns of

HIV-positive women should be required to take the drug AZT.

What did drkoop.com have to say about this smoking controversy in its section

on HIV-positive pregnant women and the chances of passing the illness on to

their babies? Nothing, actually. There was also nothing about the growing

number of HIV-positive women who’ve decided they don’t want their kids to take

AZT.

And therefore there was no mention that various medical authorities throughout

this country are trying to force some of these women to give their babies the

drug. Some who don’t comply have their children snatched from them or face

threats that they will. The drkoop.com site makes it seem as though

HIV-positive women can all freely discuss with their doctors “options” for

protecting their children against AIDS.

Well, some people don’t see it that way.

Parents’ Rights vs. Medical Dogma

Last week I met with Deane Collie, the director of the Virginia-based

International Coalition for Medical Justice, a group that fights for the right

to make medical decisions without government interference. They’re helping

women go to court to prevent doctors from giving AZT to their children. The

coalition has already heard from about 60 women who don’t believe HIV is the

cause of AIDS, and/or that AZT is going to help their youngsters. In fact, some

of the women believe AZT will harm their children. Nine legal cases are under

way, and Collie believes this is just the tip of the iceberg. She expects an

explosion of requests in the near future as state governments act to force

families to comply with AIDS treatment dogma. In Bangor, Maine,

Emerson, an HIV-positive single mother, gave birth to a daughter and son who

also turned up positive. Her daughter Tia was given AZT and died around age 4.

Emerson believes the drug hastened Tia’s death. For this reason, she stopped

the medication for her son, Nikolas. Tipped off by Nikolas’ doctor, the Maine

Department of Human Services accused Emerson of neglect and sought custody of

her son. Emerson went to court and won her case, and so far, Nikolas is doing

fine without the medication.

Mothers on the Run

In Eugene, Ore., however, Kathleen and Tyson didn’t fare so well in the

judicial system. Kathleen (who is HIV-positive) refused to give AZT to her son,

Felix (who is HIV-negative), but was forced to do so for 12 weeks by the state.

In this case, armed guards came to the maternity ward threatening to seize

Felix if the Tysons didn’t agree to allow AZT treatment. Kathleen had also

wanted to breast-feed Felix, but the court ruled against her. (Many scientists

believe HIV can be transmitted via breast milk.)

Coalition for Medical Justice Director Collie says that the group is in touch

with HIV-positive women who are on the run from the “law,” staying one step

ahead of authorities wanting to seize their children. So is the coalition a

kooky organization? Are the Emersons, Tysons and other families refusing AZT

treatment irresponsible? Or are the health authorities the ones wearing the

dunce caps?

Passions can run high in scientific circles when questions are raised about

conventional thinking in AIDS research. The use of the anti-HIV drug AZT in

children of HIV-positive mothers is just such an issue.

Consider the telephone call I made this week to Dr. Mark Wainberg, head of the

International AIDS Society: I had called Wainberg, who does AIDS research at

Montreal’s Jewish General Hospital, to interview him on the science underlying

the view that HIV-positive women should be given AZT and that their newborns

should also be put on the drug.

Holocaust Equation

I called Wainberg because he had been quoted in the Ottawa Citizen, a major

Canadian daily, saying that the dissidents were “fringe people,” and that

“There are people out there who deny that the Holocaust happened. Do we want to

give them equal credibility?” This article quoting Wainberg had been circulated

on the Web. That’s how I learned about it. Did Wainberg really make the

Holocaust comment? If so, did he really believe a comparison between mothers

fighting for their rights in the courts and those denying the Holocaust was

valid? If he indeed felt so strongly, then maybe he could document the AZT

science underlying his views.

Not only did Wainberg verify what he had said in regard to the Holocaust in the

Ottawa Citizen, but he began shouting at me, saying that if I wrote anything at

all on this issue, I would be a “child murderer.” He threatened that if I wrote

anything, he would do everything possible to get me fired from my column and my

“bosses” fired. He taunted me, saying that I wouldn’t have the guts to print

these comments. I asked him if he therefore believed that this AZT issue should

never be reported by the media. “Never,” he continued to shout. “Absolutely

never.” He then went on to condemn me again and again as a “murderer.” He also

told me that he considered any other journalist raising questions about the use

of AZT in children of HIV-positive mothers to be a child killer.

Just Don’t Ask

Wainberg, a well-recognized AIDS researcher who is one of the developers of the

anti-HIV drug 3TC, never once asked me what science questions I wanted to

explore with him, and I could barely get a word in edgewise. He had remembered

me from more than a decade ago as a Canadian medical reporter who had included

nonconventional features and commentaries on AIDS among my more mainstream AIDS

stories. Though Wainberg had taken issue with some of my reporting in those

days, I had been totally unprepared for this week’s savage assault on anyone

(including myself) who had questions about AZT treatment in pregnant

HIV-positive women and their newborns.

Considering that there is usually room for argument on scientific studies, that

there are reasonable fears about the potentially powerful side effects of AIDS

drugs, and that there may be legitimate concerns about human rights involved in

such a complex situation, I could only shake my head in amazement when I put

the phone down. Given that other scientists have also shown strong emotion in

denouncing challenges to AIDS orthodoxy, it can make you wonder what in the

world is happening to scientific debate.

Final Answers?

One key study was published on Nov. 3, 1994, in the New England Journal of

Medicine. It showed that HIV-infected mothers who received AZT gave birth to 13

HIV-positive infants, while mothers on placebos gave birth to 40 HIV-positive

infants. This small study was stopped early because of the significant

difference between the two groups and the results were immediately touted as

grounds for making AZT standard therapy for HIV-positive mothers and their

newborns. But no study comes with all the facts. The authors of the NEJM

article note, for example, that the risks and the benefits of initiating (AZT)

treatment during the first trimester of pregnancy, after 34 weeks’ gestation,

or in labor, or of treating only the newborn were not assessed. In an editorial

accompanying the study, the authors state: “The results, however, raise many

questions about the mechanism of action of (AZT), the timing of transmission,

the effectiveness of the regimen in women with clinical characteristics that

differ from those women in the trial, the long-term effects of exposure to

(AZT) during pregnancy, and the type of counseling that is appropriate to

ensure that HIV-infected women understand the benefits, risks and uncertainties

of the therapy.”

No Absolutes Except One

The authors also note that in its recommendations for AZT therapy, the public

health service emphasizes “the need for a thorough discussion of the benefits

and risks… The final decision on therapy should be made by the woman in

consultation with her health care provider.” I might add, a health provider who

is properly informed.

No study has since been published that should change the spirit of that

recommendation. While some proponents speak of the steady decline of infant and

child AIDS cases after a 1992 peak, factors such as declining births to

HIV-positive women and better prenatal care may have played a role.

Then there are the voluminous reports of adverse reactions to AZT to consider,

including the drug’s ability to damage bone marrow, kill growing cells

(particularly immune cells) by interrupting their synthesis of DNA (life’s

blueprint), and to establish itself in DNA with the potential for long-term

consequences, which includes the possibility of cancers.

Should there be widespread reporting and discussion about this entire issue?

Absolutely!

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...